Clinical trials
UDIC organises its clinical research activity in neurology and neurodegenerative diseases through clinical trials structured by medical area, study phase and participation status. The information published on this page is for informational purposes and is intended for patients, families and healthcare professionals interested in the unit’s active research lines.
Featured clinical trials
Parkinson
PARAISO — BN44715
- Medical area
- Parkinson
- Sponsor / Laboratory
- ROCHE
- Code
- BN44715
- Study name
- PARAISO
- Fase
- Fase III
- Intervention / treatment
- Prasinezumab / RO7046015 IV
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
ARISE — CVN424-301
- Medical area
- Parkinson
- Sponsor / Laboratory
- CEREVANCE
- Code
- CVN424-301
- Study name
- ARISE
- Fase
- Fase III
- Intervention / treatment
- CVN424
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
Alzheimer
MINDSET — CN012-0051
- Medical area
- Alzheimer
- Sponsor / Laboratory
- BRISTOL MYERS SQUIBB
- Code
- CN012-0051
- Study name
- MINDSET
- Fase
- Fase III
- Intervention / treatment
- KarXT (BMS-986510)
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
TRONTIER 1 — WN45443
- Medical area
- Alzheimer
- Sponsor / Laboratory
- ROCHE
- Code
- WN45443
- Study name
- TRONTIER 1
- Fase
- Fase III
- Intervention / treatment
- Trontinemab (RO7126209)
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
TRAILBLAZER-ALZ 5 — I5T-MC-AACO
- Medical area
- Alzheimer
- Sponsor / Laboratory
- LILLY
- Code
- I5T-MC-AACO
- Study name
- TRAILBLAZER-ALZ 5
- Fase
- Fase III
- Intervention / treatment
- Donanemab (LY3002813)
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
Active clinical trials
Parkinson
BEACON · DNLI-C-0009
- Medical area
- Parkinson
- Promotor
- DENALI
- Code
- DNLI-C-0009
- Study name
- BEACON
- Fase
- Fase IIa
- Intervention / treatment
- BIIB122
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LUNDBECK · LU18252A
- Medical area
- Parkinson
- Promotor
- LUNDBECK
- Code
- LU18252A
- Study name
- No especificado en origen
- Fase
- Exploratorio
- Intervention / treatment
- Lu AF28996
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
EXIST · BAN0805-201
- Medical area
- Parkinson
- Promotor
- BIOARCTIC
- Code
- BAN0805-201
- Study name
- EXIST
- Fase
- Fase IIa
- Intervention / treatment
- Exidavnemab
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LUMA · 283PD201
- Medical area
- Parkinson
- Promotor
- BIOGEN
- Code
- 283PD201
- Study name
- LUMA
- Fase
- Fase IIb
- Intervention / treatment
- BIIB122
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BouNDless · ND0612-007
- Medical area
- Parkinson
- Promotor
- NEURODERM
- Code
- ND0612-007
- Study name
- BouNDless
- Fase
- No especificada
- Intervention / treatment
- ND0612
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
PADOVA · BN42358
- Medical area
- Parkinson
- Promotor
- ROCHE
- Code
- BN42358
- Study name
- PADOVA
- Fase
- No especificada
- Intervention / treatment
- Prasinezumab IV
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
PASADENA · BP39529
- Medical area
- Parkinson
- Promotor
- ROCHE
- Code
- BP39529
- Study name
- PASADENA
- Fase
- Fase II
- Intervention / treatment
- RO7046015 (PRX002) IV
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Alzheimer
MINDSET 1 · CN012-0051
- Medical area
- Alzheimer
- Promotor
- BRISTOL MYERS SQUIBB
- Code
- CN012-0051
- Study name
- MINDSET 1
- Fase
- Fase III
- Intervention / treatment
- KarXT + KarX-EC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
RETAIN · 64042056ALZ2001
- Medical area
- Alzheimer
- Promotor
- JANSSEN
- Code
- 64042056ALZ2001
- Study name
- RETAIN
- Fase
- No especificada
- Intervention / treatment
- JNJ-64042056
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
COGNIKET-MCI · 2302-CLI
- Medical area
- Alzheimer
- Promotor
- NESTÉ HEALTH SCIENCES
- Code
- 2302-CLI
- Study name
- COGNIKET-MCI
- Fase
- No especificada
- Intervention / treatment
- Triglicéridos de cadena media cetogénicos (kMCT) y vitaminas B
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BrainShuttle AD · BP42155
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- BP42155
- Study name
- BrainShuttle AD
- Fase
- No especificada
- Intervention / treatment
- Ro7126209
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ALTITUDE-AD · ACU193-201
- Medical area
- Alzheimer
- Promotor
- ACUMEN
- Code
- ACU193-201
- Study name
- ALTITUDE-AD
- Fase
- Fase II/III
- Intervention / treatment
- ACU193 IV
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
TARGET TAU-1 · CN008-003
- Medical area
- Alzheimer
- Promotor
- BRISTOL MYERS SQUIBB
- Code
- CN008-003
- Study name
- TARGET TAU-1
- Fase
- No especificada
- Intervention / treatment
- BMS-986446
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GABRIELLA · BP44745
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- BP44745
- Study name
- GABRIELLA
- Fase
- Fase II
- Intervention / treatment
- RO7269162
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
EVOKE · NN6535-4730
- Medical area
- Alzheimer
- Promotor
- NOVO NORDISK
- Code
- NN6535-4730
- Study name
- EVOKE
- Fase
- Fase III
- Intervention / treatment
- Semaglutida oral
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
EVOKE Plus · NN6535-4725
- Medical area
- Alzheimer
- Promotor
- NOVO NORDISK
- Code
- NN6535-4725
- Study name
- EVOKE Plus
- Fase
- No especificada
- Intervention / treatment
- Semaglutida oral
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
AuTonomy · 63733657ALZ2002
- Medical area
- Alzheimer
- Promotor
- JANSSEN
- Code
- 63733657ALZ2002
- Study name
- AuTonomy
- Fase
- Fase II
- Intervention / treatment
- JNJ-63733657
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Clinical trials in other therapeutic areas
FLEX · IMVT-1401-301
- Medical area
- Myasthenia gravis generalizada
- Promotor
- IMMUNOVANT
- Code
- IMVT-1401-301
- Study name
- FLEX
- Fase
- Fase III
- Intervention / treatment
- Batoclimab
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ALLEVIA-2 · NOE-TTS-201
- Medical area
- Tourette syndrome
- Promotor
- NOEMA
- Code
- NOE-TTS-201
- Study name
- ALLEVIA-2
- Fase
- Fase II/III
- Intervention / treatment
- Gemlapodect
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
FALCON · KL1333-2020-104A
- Medical area
- Primary mitochondrial disease
- Promotor
- ABLIVA
- Code
- KL1333-2020-104A
- Study name
- FALCON
- Fase
- Fase III
- Intervention / treatment
- KL1333
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
PROPEL · IMVT-1402-3101
- Medical area
- Myasthenia gravis generalizada
- Promotor
- IMMUNOVANT
- Code
- IMVT-1402-3101
- Study name
- PROPEL
- Fase
- Information pending update by UDIC
- Intervention / treatment
- Information pending update by UDIC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
KEDRION · KB071
- Medical area
- Other areas
- Promotor
- KEDRION
- Code
- KB071
- Study name
- No especificado en origen
- Fase
- Information pending update by UDIC
- Intervention / treatment
- Information pending update by UDIC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Ongoing
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Future projects
NOVARTIS · CVHB937A12201
- Medical area
- Alzheimer
- Promotor
- NOVARTIS
- Code
- CVHB937A12201
- Study name
- No especificado en origen
- Fase
- No especificada
- Intervention / treatment
- VHB937
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Future trial
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS
- Medical area
- Alzheimer
- Promotor
- NOVARTIS
- Code
- No especificado en origen
- Study name
- No especificado en origen
- Fase
- Information pending update by UDIC
- Intervention / treatment
- Information pending update by UDIC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Future trial
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
mEADow · BP45770
- Medical area
- Parkinson
- Promotor
- ROCHE
- Code
- BP45770
- Study name
- mEADow
- Fase
- Information pending update by UDIC
- Intervention / treatment
- Information pending update by UDIC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Future trial
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ALNYLAM · ALN-5288-001
- Medical area
- Alzheimer
- Promotor
- ALNYLAM
- Code
- ALN-5288-001
- Study name
- No especificado en origen
- Fase
- Information pending update by UDIC
- Intervention / treatment
- Information pending update by UDIC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Future trial
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CNIO752A12301
- Medical area
- Alzheimer
- Promotor
- NOVARTIS
- Code
- CNIO752A12301
- Study name
- No especificado en origen
- Fase
- Information pending update by UDIC
- Intervention / treatment
- Information pending update by UDIC
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Future trial
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Archive by disease
Browse by disease and phase. Active, other therapeutic areas, future and historical trials are in the sections above.
How to browse the trials
You can start from quick access, open the therapeutic area you need, or go straight to a disease page. At the second level you will see the available phases; at the third, the card for each trial.
La enfermedad de Parkinson afecta el movimiento, el equilibrio y la calidad de vida. En UDIC se investigan nuevas opciones terapéuticas bajo protocolos revisados y supervisados.
Alzheimer’s disease and related cognitive disorders require continuous research. UDIC participates in studies at different stages of development.
Generalised myasthenia gravis is a neuromuscular disease. The trials evaluate treatments aimed at improving symptom control.
El síndrome de Tourette se caracteriza por tics motores y vocales. La investigación explora terapias para mejorar la vida diaria.
Las enfermedades mitocondriales primarias son trastornos metabólicos complejos evaluados en protocolos especializados.
La PSP es una neurodegeneración que afecta el movimiento y funciones cognitivas. La investigación busca opciones terapéuticas específicas.
Fragile X syndrome is a genetic condition. Clinical studies evaluate interventions across different age groups.
Multiple sclerosis is a demyelinating disease. UDIC documents studies on disease progression and treatment.
Epilepsy includes different types of seizures. Trials evaluate new treatments under medical supervision.
Incluye ictus y trastornos del riego cerebral. La investigación aborda prevención y recuperación.
It affects rest and may be associated with other sleep disorders. Trials evaluate therapeutic options.
Trials managed by UDIC outside the strictly neurological field, when they form part of its research activity.
Studies under review or institutional notices pending final classification by UDIC.
Historical trials
Closed, completed or archived studies. Kept separate from active trials.
TemPo-4 · CVL-751-PD-004
- Medical area
- PARKINSON
- Promotor
- Cerevel
- Code
- CVL-751-PD-004
- Study name
- TemPo-4
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
TemPo-1 · CVL-751-PD-001
- Medical area
- PARKINSON
- Promotor
- Cerevel
- Code
- CVL-751-PD-001
- Study name
- TemPo-1
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Annovis · ANVS-22001
- Medical area
- PARKINSON
- Promotor
- Annovis
- Code
- ANVS-22001
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
PROSEEK · SPARC CRL18-06
- Medical area
- PARKINSON
- Promotor
- Sun Pharma
- Code
- SPARC CRL18-06
- Study name
- PROSEEK
- Fase
- Fase 2
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
TemPo-3 · CVL-751-PD-003
- Medical area
- PARKINSON
- Promotor
- Cerevel
- Code
- CVL-751-PD-003
- Study name
- TemPo-3
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
REASON · 254PD101
- Medical area
- PARKINSON
- Promotor
- Biogen
- Code
- 254PD101
- Study name
- REASON
- Fase
- Fase 1
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ASTORIA · JM010-CS03
- Medical area
- PARKINSON
- Promotor
- Contera
- Code
- JM010-CS03
- Study name
- ASTORIA
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LIGHTHOUSE · 283PD302
- Medical area
- PARKINSON
- Promotor
- Biogen
- Code
- 283PD302
- Study name
- LIGHTHOUSE
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Sunovion · CTH-301
- Medical area
- PARKINSON
- Promotor
- Sunovion
- Code
- CTH-301
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Farma Two · P2B001-003
- Medical area
- PARKINSON
- Promotor
- Farma Two
- Code
- P2B001-003
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Impax · IPX203-B16-03
- Medical area
- PARKINSON
- Promotor
- Impax
- Code
- IPX203-B16-03
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
RISE-PD · IPX203-B16-02
- Medical area
- PARKINSON
- Promotor
- Impax
- Code
- IPX203-B16-02
- Study name
- RISE-PD
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Sunovion · CTH-302
- Medical area
- PARKINSON
- Promotor
- Sunovion
- Code
- CTH-302
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
SPARK · 228PD201
- Medical area
- PARKINSON
- Promotor
- Biogen
- Code
- 228PD201
- Study name
- SPARK
- Fase
- Fase 2
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
AMBLED · PXT-CL17-001
- Medical area
- PARKINSON
- Promotor
- Prexton
- Code
- PXT-CL17-001
- Study name
- AMBLED
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Intec Pharma · IN11004
- Medical area
- PARKINSON
- Promotor
- Intec Pharma
- Code
- IN11004
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Biotie/Acorda · TOZ CL-05
- Medical area
- PARKINSON
- Promotor
- Biotie/Acorda
- Code
- TOZ CL-05
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Civitas/Acorda · CVT-301-004
- Medical area
- PARKINSON
- Promotor
- Civitas/Acorda
- Code
- CVT-301-004
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Civitas/Acorda · CVT-301-005
- Medical area
- PARKINSON
- Promotor
- Civitas/Acorda
- Code
- CVT-301-005
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ALLAYD-II · OS320-3006
- Medical area
- PARKINSON
- Promotor
- Osmotica
- Code
- OS320-3006
- Study name
- ALLAYD-II
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ALLAYD-I · OS320-3005
- Medical area
- PARKINSON
- Promotor
- Osmotica
- Code
- OS320-3005
- Study name
- ALLAYD-I
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Bial · BIA 91067-301
- Medical area
- PARKINSON
- Promotor
- Bial
- Code
- BIA 91067-301
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Mundipharma · OXN 2504
- Medical area
- PARKINSON
- Promotor
- Mundipharma
- Code
- OXN 2504
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CAFQ056 A2299
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CAFQ056 A2299
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CAFQ056 A2223
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CAFQ056 A2223
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CAFQ056 A2222
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CAFQ056 A2222
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Merck Schering Plough · P05664
- Medical area
- PARKINSON
- Promotor
- Merck Schering Plough
- Code
- P05664
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Merck Schering Plough · P06153
- Medical area
- PARKINSON
- Promotor
- Merck Schering Plough
- Code
- P06153
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Merck Schering Plough · P04938
- Medical area
- PARKINSON
- Promotor
- Merck Schering Plough
- Code
- P04938
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schwarz Biosciences (UCB) · SP1066
- Medical area
- PARKINSON
- Promotor
- Schwarz Biosciences (UCB)
- Code
- SP1066
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Merck Serono · OLE28850
- Medical area
- PARKINSON
- Promotor
- Merck Serono
- Code
- OLE28850
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Merck Serono · EMR 701165-024
- Medical area
- PARKINSON
- Promotor
- Merck Serono
- Code
- EMR 701165-024
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Impax Pharmaceuticals · IPX066-B09-03
- Medical area
- PARKINSON
- Promotor
- Impax Pharmaceuticals
- Code
- IPX066-B09-03
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Impax Pharmaceuticals · IPX066-B09-02
- Medical area
- PARKINSON
- Promotor
- Impax Pharmaceuticals
- Code
- IPX066-B09-02
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CAFQ056A2208
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CAFQ056A2208
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Acadia · ACP-103-014
- Medical area
- PARKINSON
- Promotor
- Acadia
- Code
- ACP-103-014
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Boehringer-Ingelheim · BI 248.634
- Medical area
- PARKINSON
- Promotor
- Boehringer-Ingelheim
- Code
- BI 248.634
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Boehringer-Ingelheim · BI 248.525
- Medical area
- PARKINSON
- Promotor
- Boehringer-Ingelheim
- Code
- BI 248.525
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GSK · RO105323
- Medical area
- PARKINSON
- Promotor
- GSK
- Code
- RO105323
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schwarz Pharma · SP 873
- Medical area
- PARKINSON
- Promotor
- Schwarz Pharma
- Code
- SP 873
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schwarz Pharma · SP 833
- Medical area
- PARKINSON
- Promotor
- Schwarz Pharma
- Code
- SP 833
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schwarz Pharma · SP 825
- Medical area
- PARKINSON
- Promotor
- Schwarz Pharma
- Code
- SP 825
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schwarz Pharma · SP 516
- Medical area
- PARKINSON
- Promotor
- Schwarz Pharma
- Code
- SP 516
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schwarz Pharma · SP 515
- Medical area
- PARKINSON
- Promotor
- Schwarz Pharma
- Code
- SP 515
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CENA 713-IA 05
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CENA 713-IA 05
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CENA 713-B2311 E1
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CENA 713-B2311 E1
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CENA 713-B2311
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CENA 713-B2311
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Novartis · CCOM998 IA04
- Medical area
- PARKINSON
- Promotor
- Novartis
- Code
- CCOM998 IA04
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Schering AG · Lisuride
- Medical area
- PARKINSON
- Promotor
- Schering AG
- Code
- No especificado en origen
- Study name
- Lisuride
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ASCENT-2 · PRX012-102
- Medical area
- Alzheimer
- Promotor
- PROTHENA
- Code
- PRX012-102
- Study name
- ASCENT-2
- Fase
- Fase 1
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ABRO-AD · M23-515
- Medical area
- Alzheimer
- Promotor
- ABBVIE
- Code
- M23-515
- Study name
- ABRO-AD
- Fase
- Fase 2B
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
TOGETHER · AH003
- Medical area
- Alzheimer
- Promotor
- UCB
- Code
- AH003
- Study name
- TOGETHER
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
CLARITY · BAN2401-G000-301
- Medical area
- Alzheimer
- Promotor
- EISAI
- Code
- BAN2401-G000-301
- Study name
- CLARITY
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
OLE · BAN2401-G000-201
- Medical area
- Alzheimer
- Promotor
- EISAI
- Code
- BAN2401-G000-201
- Study name
- OLE
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
TRAILRUNNER-ALZ 2 · J1G-MC-LAKD
- Medical area
- Alzheimer
- Promotor
- LILLY
- Code
- J1G-MC-LAKD
- Study name
- TRAILRUNNER-ALZ 2
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BIAL · BIA 28-6156-201
- Medical area
- Alzheimer
- Promotor
- BIAL
- Code
- BIA 28-6156-201
- Study name
- No especificado en origen
- Fase
- Fase 2
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NEURIMMUNE · NI004-201
- Medical area
- Alzheimer
- Promotor
- NEURIMMUNE
- Code
- NI004-201
- Study name
- No especificado en origen
- Fase
- Fase 1B/2
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
HARBOR · M22-721
- Medical area
- Alzheimer
- Promotor
- ABBVIE
- Code
- M22-721
- Study name
- HARBOR
- Fase
- Fase 1B/2
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ASPECT · 20-AVP-786-307
- Medical area
- Alzheimer
- Promotor
- AVANIR
- Code
- 20-AVP-786-307
- Study name
- ASPECT
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LUCIDITY · TRx-237-039
- Medical area
- Alzheimer
- Promotor
- TauRx Therapeutics
- Code
- TRx-237-039
- Study name
- LUCIDITY
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GRADUATE · WN29922
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- WN29922
- Study name
- GRADUATE
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GAIN · COR388-010
- Medical area
- Alzheimer
- Promotor
- CORTEXYME
- Code
- COR388-010
- Study name
- GAIN
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ACADIA · ACP-103-045
- Medical area
- Alzheimer
- Promotor
- ACADIA
- Code
- ACP-103-045
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BOEHRINGER-INGELHEIM · 1346.23
- Medical area
- Alzheimer
- Promotor
- BOEHRINGER-INGELHEIM
- Code
- 1346.23
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
MISSION AD · E2609-G000-301
- Medical area
- Alzheimer
- Promotor
- EISAI
- Code
- E2609-G000-301
- Study name
- MISSION AD
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
HEPTARES · HTL0018318-202
- Medical area
- Alzheimer
- Promotor
- HEPTARES
- Code
- HTL0018318-202
- Study name
- No especificado en origen
- Fase
- Fase 1B
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
EARLY · 54861911ALZ2003
- Medical area
- Alzheimer
- Promotor
- JANSSEN
- Code
- 54861911ALZ2003
- Study name
- EARLY
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
AXOVANT · RVT-101-3002
- Medical area
- Alzheimer
- Promotor
- AXOVANT
- Code
- RVT-101-3002
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
AXOVANT · RVT-101-3001
- Medical area
- Alzheimer
- Promotor
- AXOVANT
- Code
- RVT-101-3001
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
CREAD OLE · BN40031
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- BN40031
- Study name
- CREAD OLE
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
CREAD2 · BN 29553
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- BN 29553
- Study name
- CREAD2
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
CREAD · BN 29552
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- BN 29552
- Study name
- CREAD
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
EMERGE · 221AD301
- Medical area
- Alzheimer
- Promotor
- BIOGEN
- Code
- 221AD301
- Study name
- EMERGE
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
DAYBREAK · I8D-MC-AZET
- Medical area
- Alzheimer
- Promotor
- LILLY / ASTRAZENECA
- Code
- I8D-MC-AZET
- Study name
- DAYBREAK
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
AMARANTH · AZD3293
- Medical area
- Alzheimer
- Promotor
- ASTRAZENECA / LILLY
- Code
- AZD3293
- Study name
- AMARANTH
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BOEHRINGER INGELHEIM · 1289.5
- Medical area
- Alzheimer
- Promotor
- BOEHRINGER INGELHEIM
- Code
- 1289.5
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LILLY · H8A-MC-LZAX
- Medical area
- Alzheimer
- Promotor
- LILLY
- Code
- H8A-MC-LZAX
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
AMBAR · IG1002
- Medical area
- Alzheimer
- Promotor
- GRIFOLS
- Code
- IG1002
- Study name
- AMBAR
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LUNDBECK · LU14863
- Medical area
- Alzheimer
- Promotor
- LUNDBECK
- Code
- LU14863
- Study name
- No especificado en origen
- Fase
- Fase 3
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Memantina · LU14861B
- Medical area
- Alzheimer
- Promotor
- LUNDBECK
- Code
- LU14861B
- Study name
- Memantina
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LUNDBECK · LU14861A
- Medical area
- Alzheimer
- Promotor
- LUNDBECK
- Code
- LU14861A
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LUPIN · LRP/LND101001
- Medical area
- Alzheimer
- Promotor
- LUPIN
- Code
- LRP/LND101001
- Study name
- No especificado en origen
- Fase
- Fase 2
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
EISAI · BAN2401-G000-201
- Medical area
- Alzheimer
- Promotor
- EISAI
- Code
- BAN2401-G000-201
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
SERVIER · CL2-38093-012
- Medical area
- Alzheimer
- Promotor
- SERVIER
- Code
- CL2-38093-012
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ROCHE · BP 28248
- Medical area
- Alzheimer
- Promotor
- ROCHE
- Code
- BP 28248
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GENENTECH (ROCHE) · GN 28525
- Medical area
- Alzheimer
- Promotor
- GENENTECH (ROCHE)
- Code
- GN 28525
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LILLY · 140-MC-BACC
- Medical area
- Alzheimer
- Promotor
- LILLY
- Code
- 140-MC-BACC
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GENENTECH (ROCHE) · GN ABE 4869g
- Medical area
- Alzheimer
- Promotor
- GENENTECH (ROCHE)
- Code
- GN ABE 4869g
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CAD106 A2203
- Medical area
- Alzheimer
- Promotor
- NOVARTIS
- Code
- CAD106 A2203
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
GSK · AVA 105640
- Medical area
- Alzheimer
- Promotor
- GSK
- Code
- AVA 105640
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CENA 713-ES-02
- Medical area
- Alzheimer
- Promotor
- NOVARTIS
- Code
- CENA 713-ES-02
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Alfa Bioresearch · AB 13004
- Medical area
- Progressive supranuclear palsy
- Promotor
- Alfa Bioresearch
- Code
- AB 13004
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
PASSPORT · CN 002-012 / 251PP301
- Medical area
- Progressive supranuclear palsy
- Promotor
- BRISTOL MYERS SQUIB / BIOGEN
- Code
- CN 002-012 / 251PP301
- Study name
- PASSPORT
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
UCB · PSP003
- Medical area
- Progressive supranuclear palsy
- Promotor
- UCB
- Code
- PSP003
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CAFQ056 A2212
- Medical area
- Fragile X syndrome
- Promotor
- NOVARTIS
- Code
- CAFQ056 A2212
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CAFQ056 B2214
- Medical area
- Fragile X syndrome
- Promotor
- NOVARTIS
- Code
- CAFQ056 B2214
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CAFQ056 B2279
- Medical area
- Fragile X syndrome
- Promotor
- NOVARTIS
- Code
- CAFQ056 B2279
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CAFQ056 B2278
- Medical area
- Fragile X syndrome
- Promotor
- NOVARTIS
- Code
- CAFQ056 B2278
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS
- Medical area
- Fragile X syndrome
- Promotor
- NOVARTIS
- Code
- No especificado en origen
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ROCHE · NP27936
- Medical area
- Fragile X syndrome
- Promotor
- ROCHE
- Code
- NP27936
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NURON · NU-100-101
- Medical area
- Multiple sclerosis
- Promotor
- NURON
- Code
- NU-100-101
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
NOVARTIS · CFTY 720 D2402
- Medical area
- Multiple sclerosis
- Promotor
- NOVARTIS
- Code
- CFTY 720 D2402
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BIAL · IMDYVA
- Medical area
- Epilepsy
- Promotor
- BIAL
- Code
- IMDYVA
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BIAL · BIA 2093-311
- Medical area
- Epilepsy
- Promotor
- BIAL
- Code
- BIA 2093-311
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
UCB · SP 0980
- Medical area
- Epilepsy
- Promotor
- UCB
- Code
- SP 0980
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
ASTRA · CLASS
- Medical area
- Cerebrovascular disease
- Promotor
- ASTRA
- Code
- CLASS
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
URIACH · TACIP
- Medical area
- Cerebrovascular disease
- Promotor
- URIACH
- Code
- TACIP
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BOEHRINGER-INGELHEIM · BI 248.604
- Medical area
- Restless legs syndrome
- Promotor
- BOEHRINGER-INGELHEIM
- Code
- BI 248.604
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BOEHRINGER-INGELHEIM · BI 248.615
- Medical area
- Restless legs syndrome
- Promotor
- BOEHRINGER-INGELHEIM
- Code
- BI 248.615
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
BOEHRINGER-INGELHEIM · BI 248.641
- Medical area
- Tourette syndrome
- Promotor
- BOEHRINGER-INGELHEIM
- Code
- BI 248.641
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
OTSUKA · 31-12-293
- Medical area
- Tourette syndrome
- Promotor
- OTSUKA
- Code
- 31-12-293
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
CB-01-11/28 · CRO-16-130 S
- Medical area
- Non-neurological clinical trials
- Promotor
- COSMO
- Code
- CRO-16-130 S
- Study name
- CB-01-11/28
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
LEON FARMA · CF 111/302
- Medical area
- Non-neurological clinical trials
- Promotor
- LEON FARMA
- Code
- CF 111/302
- Study name
- No especificado en origen
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
PERSPECTIVE · CLCZ696B2320
- Medical area
- Non-neurological clinical trials
- Promotor
- NOVARTIS
- Code
- CLCZ696B2320
- Study name
- PERSPECTIVE
- Fase
- No especificada en origen
- Intervention / treatment
- Consultar protocolo con UDIC.
- Description
- Detailed information about this study is available from UDIC upon request.
- Status
- Histórico
- Información para pacientes
- Consultar con UDIC.
- Information for professionals
- Information available under review by the UDIC team.
Move window